Prescott Group Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93M | Buy |
772,771
+145,100
| +23% | +$926K | 0.58% | 40 |
|
|
2025
Q1 | $3.05M | Buy |
627,671
+417,671
| +199% | +$2.03M | 0.44% | 71 |
|
|
2024
Q4 | $2.01M | Buy |
210,000
+150,000
| +250% | +$1.43M | 0.27% | 116 |
|
|
2024
Q3 | $501K | Buy |
+60,000
| New | +$501K | 0.07% | 199 |
|
|
2024
Q1 | – | Sell |
-853,349
| Closed | -$2.05M | – | 209 |
|
|
2023
Q4 | $2.05M | Buy |
853,349
+554,162
| +185% | +$1.33M | 0.36% | 87 |
|
|
2023
Q3 | $1.02M | Sell |
299,187
-7,651
| -2% | -$26K | 0.23% | 113 |
|
|
2023
Q2 | $2.26M | Buy |
+306,838
| New | +$2.26M | 0.49% | 59 |
|
|
2023
Q1 | – | Sell |
-91,000
| Closed | -$1.08M | – | 176 |
|
|
2022
Q4 | $1.08M | Buy |
+91,000
| New | +$1.08M | 0.23% | 106 |
|
|
2022
Q1 | – | Sell |
-45,693
| Closed | -$1.99M | – | 155 |
|
|
2021
Q4 | $1.99M | Buy |
+45,693
| New | +$1.99M | 0.45% | 68 |
|